Secondary hyperparathyroidism is a complex endocrine condition characterized by excess circulating parathyroid hormone (PTH) resulting from an underlying condition, most commonly chronic kidney ...
Please provide your email address to receive an email when new articles are posted on . A lower parathyroid hormone target treatment method was linked with reduced adjusted hazard of death. The ...
Hyperparathyroidism happens when the parathyroid glands make too much parathyroid hormone. This can affect your calcium levels and cause other health problems. You may have hyperparathyroidism if your ...
However, despite suggestions that such secondarily stimulated hyperparathyroidism may become autonomous 12–14 convincing data regarding such a possibility are not available, owing to the great excess ...
Hyperparathyroidism is a condition wherein the parathyroid glands create too much parathyroid hormone. This can cause the levels of calcium in the blood to rise, which, without treatment, can lead to ...
Treatment of secondary hyperparathyroidism with vitamin D and calcium in patients receiving dialysis is often complicated by hypercalcemia and hyperphosphatemia, which may contribute to cardiovascular ...
Your parathyroid glands are four tiny glands located at the four corners of your thyroid gland. They are about the size of a pea and produce hormones to regulate the calcium levels in your blood and ...
Background A 30-year-old woman with suspected multiple endocrine neoplasia type 1 (MEN1) was referred to our center in 2001 with primary hyperparathyroidism caused by a multiglandular parathyroid ...
DUBLIN--(BUSINESS WIRE)--The "Secondary Hyperparathyroidism Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook" report has been added to ...
Hyperparathyroidism can cause unusually high calcium levels in the blood. This can lead to back pain when there is damage to the kidneys or bones. It can also cause muscle pain. Share on Pinterest ...
Background: A 30-year-old woman with suspected multiple endocrine neoplasia type 1 (MEN1) was referred to our center in 2001 with primary hyperparathyroidism caused by a multiglandular parathyroid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results